BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24985891)

  • 1. Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat.
    Bertz JW; Chen J; Woods JH
    Psychopharmacology (Berl); 2015 Jan; 232(1):209-21. PubMed ID: 24985891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat.
    Bertz JW; Woods JH
    Psychopharmacology (Berl); 2013 Sep; 229(2):235-43. PubMed ID: 23609770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer.
    Bertz JW; Jackson EL; Barron DR; Woods JH
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):137-47. PubMed ID: 26580131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
    Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats.
    Collins GT; Cunningham AR; Chen J; Wang S; Newman AH; Woods JH
    Psychopharmacology (Berl); 2012 Jan; 219(1):123-35. PubMed ID: 21701814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats.
    Collins GT; Woods JH
    Behav Pharmacol; 2009 Sep; 20(5-6):492-504. PubMed ID: 19696656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dose on acquisition and persistence of a new response for a remifentanil-associated stimulus.
    Robertson SH; Jutkiewicz EM
    Behav Pharmacol; 2020 Apr; 31(2&3):207-215. PubMed ID: 32058349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer.
    McCormick PN; Fletcher PJ; Wilson VS; Browne JD; Nobrega JN; Remington GJ
    Neuropharmacology; 2015 Feb; 89():225-31. PubMed ID: 25283483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.
    Fraser KM; Haight JL; Gardner EL; Flagel SB
    Behav Brain Res; 2016 May; 305():87-99. PubMed ID: 26909847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of food restriction on the conditioned reinforcing properties of an opioid-associated stimulus.
    Robertson SH; Jutkiewicz EM
    Behav Pharmacol; 2021 Sep; 32(6):505-514. PubMed ID: 34320518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
    Collins GT; Calinski DM; Newman AH; Grundt P; Woods JH
    J Pharmacol Exp Ther; 2008 May; 325(2):691-7. PubMed ID: 18305018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological stressor yohimbine, but not U50,488, increases responding for conditioned reinforcers paired with ethanol or sucrose.
    Tabbara RI; Rahbarnia A; Lê AD; Fletcher PJ
    Psychopharmacology (Berl); 2020 Dec; 237(12):3689-3702. PubMed ID: 32840668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of conditioned reinforcing effectiveness: Dopamine D2-like receptor agonist-stimulated responding for cocaine-associated stimuli.
    Collins GT; France CP
    Eur J Pharmacol; 2015 Dec; 769():242-9. PubMed ID: 26593427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adrenergic α2 antagonist atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma.
    McCormick PN; Fletcher PJ; Wilson VS; Remington GJ
    Life Sci; 2016 Apr; 151():300-304. PubMed ID: 26976325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine enhances responding with conditioned reinforcement.
    Olausson P; Jentsch JD; Taylor JR
    Psychopharmacology (Berl); 2004 Jan; 171(2):173-8. PubMed ID: 13680077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dopamine D3 receptors in the expression of conditioned fear in rats.
    Swain SN; Beuk J; Heidbreder CA; Beninger RJ
    Eur J Pharmacol; 2008 Jan; 579(1-3):167-76. PubMed ID: 17996231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.
    Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
    Guy EG; Fletcher PJ
    Pharmacol Biochem Behav; 2014 Oct; 125():40-47. PubMed ID: 25158104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.
    Chang WL; Breier MR; Yang A; Swerdlow NR
    Pharmacol Biochem Behav; 2011 Oct; 99(4):634-8. PubMed ID: 21683731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P; Scorza C; Monti JM; Jantos H; Reyes-Parada M; Silveira R; Ponzoni A
    Eur Neuropsychopharmacol; 1998 May; 8(2):113-20. PubMed ID: 9619689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.